The American Society of Hematology released evidence-based guidelines for the treatment of DVT and PE in patients without cancer.
In the event of a likely scarcity of COVID-19 vaccines, a framework must be developed to inform who should get priority.
How should physicians be discussing influenza and pneumococcal vaccines with patients amidst the continuing COVID-19 pandemic?
There may be interactive health effects between the 2 crises of the COVID-19 pandemic and US wildfires.
The MET alteration occurs in 3% to 4% of patients with the condition.
Davey Smith, MD, provides insight into current and future research opportunities targeting SARS-CoV-2.
Risks of moving clinical trials online include missing key information about the patient experience — and higher dropout rates could also impair the overall quality of trials.
Findings suggest lower rates of COVID-19 infection and mortality in countries with universal neonatal BCG tuberculosis vaccination policies compared with countries without this practice.
As a central goal of PF Awareness Month and their ongoing work, the Pulmonary Fibrosis Foundation aims to improve diagnostic delays and misdiagnoses in this patient population.
Antiplatelet therapy may delay progression of COPD, decrease the risk for acute exacerbations, improve quality of life, and even reduce all-cause mortality.